• Search in Protiviti.com

Insight Search

Sort by:

  • Survey

    March 18, 2026
    2026 Global Board Governance Survey
    AI is reshaping boardroom priorities. Learn how leading boards integrate AI into strategy, governance and risk oversight in Protiviti's 2026 Global Board Governance Survey.

  • Video

    December 21, 2024
    Video | Protiviti Legal Perspectives With Managing Director Sunny Sanghani
    In this episode of the Protiviti Legal Perspectives podcast series, host Chad Volkert, Global Solutions leader at Protiviti, welcomes Sunny Sanghani, a managing director in Protiviti’s Legal Consulting practice, to discuss key trends and challenges in the legal technology landscape. With nearly 18 years of experience at Protiviti, Sunny shares a unique career journey that began in internal audit…

  • Insights paper

    November 18, 2025
    Audit Committee Self-Assessment Guide: Key Questions for 2026
    Effective audit committees continuously evaluate their roles, responsibilities, and performance to drive improvement. Our Audit Committee Self-Assessment Questions are designed to help guide committees in their evaluation.These questions are illustrative and do not purport to cover every topic the committee should consider, nor are they intended to be a one-size-fits-all approach that applies to…

  • Whitepaper

    November 18, 2025
    Setting the 2026 Audit Committee Agenda
    As organisations grapple with rapid technological change, evolving regulations, and increasing risks in areas like AI, cybersecurity, and data privacy, audit committees are being called on to broaden their view of enterprise risk and governance. With oversight responsibilities growing in both scope and complexity, this whitepaper reveals the nine critical priorities that will define effective…

  • Newsletter

    April 8, 2026
    AI Oversight: A Board Governance Imperative
    AI board governance boosts ROI and confidence—Protiviti’s survey reveals that engaged, responsible oversight empowers boards to drive value and accountable AI outcomes.

  • Podcast

    March 20, 2026
    Podcast | The Fall and Rise of a Quantum Company Boosting Algorithmic Development – with Sumit Kapur of Zapata Quantum
    Zapata’s back! A tough stretch including a difficult SPAC deal, a brief move into AI, and a $20 million debt forced the company to shut down in 2024. But in this episode, Sumit Kapur, CEO of Zapata Quantum, talks with host Konstantinos Karagiannis about how the company made a remarkable comeback. They discuss the intense restructuring, the strong support from the quantum computing industry, and…

  • Newsletter

    February 7, 2024
    The Top Risks 10 Years Out: Global Risks Are Persistent
    Capturing insights from over 1,100 C-level executives and directors across multiple industries with broad geographic representation, our global survey of C-level executives and directors survey offers insights for the top risks over the next 10 years out to 2034. The following table provides a context for understanding the most critical uncertainties companies face looking forward to 2034.TOP…

  • Newsletter

    October 22, 2024
    Private Equity Insights Q3 2024
    In this issue of Private Equity Insights, we discuss our latest Global Finance Trends Survey results. CFOs and finance leaders around the world rated their top finance priorities. Our intent is for PE firms to use this intelligence to design and deploy new practices, tools and innovative approaches in their own finance organisation. We next take a look at financial planning & analysis (FP…

  • Newsletter

    February 11, 2026
    Key Topics for the Board’s Agenda in 2026
    Set an effective board agenda for 2026, focusing on AI oversight, risk management, and strategic execution to enhance governance amid evolving challenges.

  • Whitepaper

    February 6, 2025
    Top Compliance Priorities for U.S. Healthcare Organisations in 2025
    Protiviti’s risk and compliance experts weigh in on the top compliance priorities for healthcare organisations in 2025 and what these changes mean under a new administration. Providers, payers, and life sciences organisations must refine their strategies to comply with evolving regulatory requirements and enforcement, while also capitalising on the opportunities presented by emerging…
Loading...